Evidence map›Paper›PMID 27819024›Full record

ReviewInternational journal of chronic diseases2016

Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot.

Rahul Pal, Moiz A Ansari, Saif Hameed, Zeeshan Fatima

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of chronic diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Liposomal Glutathione Helps to MitigateAntioxidants (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rahul PalAmity Institute of Biotechnology, Amity University Haryana, Gurgaon, Manesar 122413, India.
Moiz A AnsariAmity Institute of Biotechnology, Amity University Haryana, Gurgaon, Manesar 122413, India.
Saif HameedAmity Institute of Biotechnology, Amity University Haryana, Gurgaon, Manesar 122413, India.ORCID 0000-0002-6477-1870
Zeeshan FatimaAmity Institute of Biotechnology, Amity University Haryana, Gurgaon, Manesar 122413, India.ORCID 0000-0002-5084-4450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) still remains the thorn in the flesh of efficient therapeutics affecting one-third of global population annually. There are several factors that enhance the susceptibility to TB infections including malnutrition, smoking, and immunocompromised conditions such as AIDS. In the recent years, growing body of evidence has gained considerable prominence which suggests that Diabetes Mellitus (DM) is individual risk factor leading to complicated TB infections. In this article the authors have attempted to summarize the link of type 2 DM with TB, the mechanistic action of how DM sensitizes for developing the active TB infection from the latent infection, and problems faced during treatment followed by possible preventive measures. We have tried to give account of the alterations that occurred in DM making a person more prone to develop TB.

Identifiers

PMID27819024
PMCPMC5080504
OpenAlexW2531009843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.